E

EuBiologics Co Ltd
KOSDAQ:206650

Watchlist Manager
EuBiologics Co Ltd
KOSDAQ:206650
Watchlist
Price: 12 740 KRW -2% Market Closed
Market Cap: 465.4B KRW
Have any thoughts about
EuBiologics Co Ltd?
Write Note

Relative Value

The Relative Value of one EuBiologics Co Ltd stock under the Base Case scenario is 20 312.33 KRW. Compared to the current market price of 12 740 KRW, EuBiologics Co Ltd is Undervalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
20 312.33 KRW
Undervaluation 37%
Relative Value
Price
E
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
73
vs Industry
60
Median 3Y
6.7
Median 5Y
7
Industry
7.7
Forward
4.7
vs History
vs Industry
0
Median 3Y
-46.1
Median 5Y
-25.4
Industry
22.7
Forward
23.4
vs History
42
vs Industry
11
Median 3Y
22.2
Median 5Y
19.2
Industry
21.6
vs History
vs Industry
Median 3Y
-40.2
Median 5Y
-40.2
Industry
25.2
vs History
53
vs Industry
25
Median 3Y
3.8
Median 5Y
4.5
Industry
2.5
vs History
82
vs Industry
50
Median 3Y
6.7
Median 5Y
7.1
Industry
7.7
Forward
4.7
vs History
84
vs Industry
33
Median 3Y
14
Median 5Y
15
Industry
9
vs History
47
vs Industry
6
Median 3Y
62.8
Median 5Y
29
Industry
4.2
Forward
12.1
vs History
4
vs Industry
3
Median 3Y
-86.6
Median 5Y
-80.2
Industry
4.1
Forward
20
vs History
42
vs Industry
11
Median 3Y
22.3
Median 5Y
20.6
Industry
5.7
vs History
1
vs Industry
Median 3Y
-30.8
Median 5Y
-39.8
Industry
3.6
vs History
46
vs Industry
41
Median 3Y
3.1
Median 5Y
3.1
Industry
4.6

Multiples Across Competitors

Competitors Multiples
EuBiologics Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
EuBiologics Co Ltd
KOSDAQ:206650
464.4B KRW 5.4 -254.8 31.4 87.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
KR
E
EuBiologics Co Ltd
KOSDAQ:206650
Average P/E: 208.3
Negative Multiple: -254.8
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
KR
E
EuBiologics Co Ltd
KOSDAQ:206650
Average EV/EBITDA: 19.2
31.4
181%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
KR
E
EuBiologics Co Ltd
KOSDAQ:206650
Average EV/EBIT: 31.8
87.2
371%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top